{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:13:06Z","timestamp":1794600786773,"version":"4.9.1"},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T00:00:00Z","timestamp":1113436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Adoptive immunotherapy with tumour\u2010specific T cells is an emerging technology that may be applicable to a broad range of cancers. However, tumours can avoid T cell\u2010mediated attack through multiple mechanisms including downregulation of major histocompatability complex (MHC). Consequently, engineering T cells to target intact protein antigen directly, thus bypassing the need for MHC presentation, can facilitate T cell targeting of tumour cells. Peripheral blood lymphocytes from nine of nine patients with non\u2010Hodgkin lymphoma (NHL) were successfully gene\u2010modified to express a receptor consisting of a CD19 single chain variable fragment (scFv) fused to the T cell CD3<jats:italic>\u03b6<\/jats:italic> signalling molecule. These T cells were functionally active against the CD19<jats:sup>+<\/jats:sup> Raji Burkitt's lymphoma cell line. Importantly, engineered T cells from seven of nine NHL patients efficiently lysed autologous lymph node tumour biopsy cells. There was a clear correlation between levels of CD19 expression on the tumour and effective killing by the engineered T cells. For two patients with a low or absent CD19<jats:sup>+<\/jats:sup> cells within the biopsy, no significant killing was observed. These results demonstrate that patients with CD19<jats:sup>+<\/jats:sup> NHL would be suitable candidates for this form of therapy in the setting of a phase I clinical trial.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2005.05456.x","type":"journal-article","created":{"date-parts":[[2005,7,5]],"date-time":"2005-07-05T18:39:56Z","timestamp":1120588796000},"page":"322-332","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Killing of non\u2010Hodgkin lymphoma cells by autologous CD19 engineered T cells"],"prefix":"10.1111","volume":"129","author":[{"given":"Eleanor J.","family":"Cheadle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gilham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C.","family":"Thistlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,4,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.8.3983"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200405000-00007"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1388"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5319.1719"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm827"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92695-6"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1989"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702363"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.11.4297"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076514"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200205000-00007"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200303000-00002"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301828"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.1.43.43"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri859"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90264-L"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200203000-00002"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088547"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood.V83.11.3279.3279","article-title":"Idiotypic vaccination against human B\u2010cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single\u2010chain Fv personal vaccines","volume":"83","author":"Hawkins R.E.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.182"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1041"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01490-1"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1549"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403302"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(96)00115-9"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700477"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2457.2457"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb03118.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.785"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2800"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.138.9.2793","article-title":"CD19 monoclonal antibody HD37 inhibits anti\u2010immunoglobulin\u2010induced B cell activation and proliferation","volume":"138","author":"Pezzutto A.","year":"1987","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_34_1","first-page":"2470","article-title":"Immuno\u2010gene therapy of established prostate tumors using chimeric receptor\u2010redirected human lymphocytes","volume":"63","author":"Pinthus J.H.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05077.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405730101"},{"key":"e_1_2_6_37_1","first-page":"608","article-title":"Expression and function of the peptide transporters in escape variants of human renal cell carcinomas","volume":"25","author":"Seliger B.","year":"1997","journal-title":"Experimental Hematology"},{"key":"e_1_2_6_38_1","first-page":"1349","article-title":"Induction of CD80 expression in low\u2010grade B cell lymphoma\u2013a potential immunotherapeutic target","volume":"9","author":"Shamash J.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_39_1","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu J.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_40_1","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.4049\/jimmunol.151.11.6577","article-title":"Targeting of T lymphocytes to Neu\/HER2\u2010expressing cells using chimeric single chain Fv receptors","volume":"151","author":"Stancovski I.","year":"1993","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.143.2.712","article-title":"Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily","volume":"143","author":"Tedder T.F.","year":"1989","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80418-5"},{"key":"e_1_2_6_43_1","first-page":"3562","article-title":"A phase I trial of CD3\/CD28\u2010activated T cells (Xcellerated T cells) and interleukin\u20102 in patients with metastatic renal cell carcinoma","volume":"9","author":"Thompson J.A.","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.1.13.13"},{"key":"e_1_2_6_45_1","first-page":"467","article-title":"Long\u2010term in vivo survival of receptor\u2010modified syngeneic T cells in patients with human immunodeficiency virus infection","volume":"96","author":"Walker R.E.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2003.12.011"},{"key":"e_1_2_6_47_1","first-page":"606","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf A.M.","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242600099"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2005.05456.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2005.05456.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:25:13Z","timestamp":1697419513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2005.05456.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,19]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1365-2141.2005.05456.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05456.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,19]]},"assertion":[{"value":"2005-04-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}